TAP block given for pain management before the start of laproscopic Gynecological Surgeries during and after the operatio
Phase 4
- Conditions
- Health Condition 1: N719- Inflammatory disease of uterus, unspecified
- Registration Number
- CTRI/2022/10/046247
- Lead Sponsor
- RRMCH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.ASA I to II Patients of female sex.
2.Aged between 18 to 60 years.
3 Undergoing Elective laparoscopic gynaecology
surgery- LAVH/TLH
Exclusion Criteria
a)Patients with history of allergy to local anesthetics
b)Patients with history of mental disorders.
c)Patient Refusal.
d)Morbid obesity, Coagulopathy and significant cardiovascular respiratory, renal, hepatic or metabolic diseases or CNS disorders.
e)Infection at site of procedure
f)Surgery more than 3 hours duration
g)ASA III and IV.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the effectiveness of preoperative TAP block for Intra-operative analgesia in patients undergoing Laparoscopic gynaecological surgeries.Timepoint: To Note VAS score at 0,2,4,6,8,10,12,14,16,18,24 <br/ ><br>hours
- Secondary Outcome Measures
Name Time Method To compare total intraoperative opiod <br/ ><br>consumption in both groups <br/ ><br>Intraoperative Muscle relaxant and volatile anesthetic consumption. Hemodynamic <br/ ><br>parameterTimepoint: 15,30,45,60,75,90,120,180 minutes <br/ ><br>intraoperatively and 1,2,4,8,12,24 hours <br/ ><br>postoperatively